{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T12:13:33Z","timestamp":1783426413281,"version":"3.54.6"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Gift from J.D. and Jill Thoreson of Mason City, Iowa"},{"name":"Maxene Spohnheimer Thyroid Cancer Research Fund"},{"name":"National Cancer Institute of the National Institutes of Health under the Cancer Center Support Grant","award":["P30CA 86862"],"award-info":[{"award-number":["P30CA 86862"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-50784-9","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T05:42:21Z","timestamp":1778046141000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Improving predicted risk of recurrence using molecular profiling in papillary thyroid cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Zhijie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo M.","family":"Ng Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria L.","family":"Deters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Kenny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald J.","family":"Weigel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna C.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"issue":"6","key":"50784_CR1","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.surg.2013.07.008","volume":"154","author":"RH Grogan","year":"2013","unstructured":"Grogan, R. H. et al. A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up. Surgery 154(6), 1436\u20131446. https:\/\/doi.org\/10.1016\/j.surg.2013.07.008 (2013) (discussion 46-7).","journal-title":"Surgery"},{"key":"50784_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9989757","volume":"2021","author":"W Chatchomchuan","year":"2021","unstructured":"Chatchomchuan, W. et al. Recurrence factors and characteristic trends of papillary thyroid cancer over three decades. Int. J. Endocrinol. 2021, 9989757. https:\/\/doi.org\/10.1155\/2021\/9989757 (2021).","journal-title":"Int. J. Endocrinol."},{"issue":"1","key":"50784_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H. & Jemal, A. Cancer statistics, 2025. CA. Cancer J. Clin. 75(1), 10\u201345. https:\/\/doi.org\/10.3322\/caac.21871 (2025).","journal-title":"CA. Cancer J. Clin."},{"issue":"1","key":"50784_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen, B. R. et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1), 1\u2013133. https:\/\/doi.org\/10.1089\/thy.2015.0020 (2016).","journal-title":"Thyroid"},{"issue":"12","key":"50784_CR5","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1089\/thy.2010.0178","volume":"20","author":"RM Tuttle","year":"2010","unstructured":"Tuttle, R. M. et al. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: Using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid 20(12), 1341\u20131349. https:\/\/doi.org\/10.1089\/thy.2010.0178 (2010).","journal-title":"Thyroid"},{"issue":"6","key":"50784_CR6","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1089\/thy.2017.0102","volume":"27","author":"RM Tuttle","year":"2017","unstructured":"Tuttle, R. M., Haugen, B. & Perrier, N. D. Updated American Joint Committee on Cancer\/Tumor-Node-Metastasis staging system for differentiated and anaplastic thyroid cancer (eighth edition): What changed and why?. Thyroid 27(6), 751\u2013756. https:\/\/doi.org\/10.1089\/thy.2017.0102 (2017).","journal-title":"Thyroid"},{"issue":"4","key":"50784_CR7","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/jnci\/djj052","volume":"98","author":"C Sotiriou","year":"2006","unstructured":"Sotiriou, C. et al. Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis. J. Natl. Cancer Inst. 98(4), 262\u2013272. https:\/\/doi.org\/10.1093\/jnci\/djj052 (2006).","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"50784_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001453","volume":"10","author":"L Marisa","year":"2013","unstructured":"Marisa, L. et al. Gene expression classification of colon cancer into molecular subtypes: Characterization, validation, and prognostic value. PLoS. Med. 10(5), e1001453. https:\/\/doi.org\/10.1371\/journal.pmed.1001453 (2013).","journal-title":"PLoS. Med."},{"issue":"2","key":"50784_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.suronc.2015.02.001","volume":"24","author":"YN You","year":"2015","unstructured":"You, Y. N., Rustin, R. B. & Sullivan, J. D. Oncotype DX((R)) colon cancer assay for prediction of recurrence risk in patients with stage II and III colon cancer: A review of the evidence. Surg. Oncol. 24(2), 61\u201366. https:\/\/doi.org\/10.1016\/j.suronc.2015.02.001 (2015).","journal-title":"Surg. Oncol."},{"issue":"6","key":"50784_CR10","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/BF03256259","volume":"11","author":"AK Conlin","year":"2007","unstructured":"Conlin, A. K. & Seidman, A. D. Use of the Oncotype DX 21-gene assay to guide adjuvant decision making in early-stage breast cancer. Mol. Diagn. Ther. 11(6), 355\u2013360. https:\/\/doi.org\/10.1007\/BF03256259 (2007).","journal-title":"Mol. Diagn. Ther."},{"key":"50784_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1508404","volume":"16","author":"J Liu","year":"2025","unstructured":"Liu, J. et al. Molecular testing stratifies the risk of structural recurrence in high risk differentiated thyroid cancer: A retrospective cohort study. Front. Endocrinol. (Lausanne) 16, 1508404. https:\/\/doi.org\/10.3389\/fendo.2025.1508404 (2025).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"8","key":"50784_CR12","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1007\/s00268-020-05521-2","volume":"44","author":"S Enumah","year":"2020","unstructured":"Enumah, S. et al. BRAF(V600E) mutation is associated with an increased risk of papillary thyroid cancer recurrence. World J. Surg. 44(8), 2685\u20132691. https:\/\/doi.org\/10.1007\/s00268-020-05521-2 (2020).","journal-title":"World J. Surg."},{"issue":"1","key":"50784_CR13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.surg.2022.05.048","volume":"173","author":"JB Liu","year":"2023","unstructured":"Liu, J. B. et al. Association of comprehensive thyroid cancer molecular profiling with tumor phenotype and cancer-specific outcomes. Surgery 173(1), 252\u2013259. https:\/\/doi.org\/10.1016\/j.surg.2022.05.048 (2023).","journal-title":"Surgery"},{"issue":"5","key":"50784_CR14","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1210\/clinem\/dgab836","volume":"107","author":"HR Nieto","year":"2022","unstructured":"Nieto, H. R. et al. Recurrence of papillary thyroid cancer: A systematic appraisal of risk factors. J. Clin. Endocrinol. Metab. 107(5), 1392\u20131406. https:\/\/doi.org\/10.1210\/clinem\/dgab836 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"50784_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12146-4","volume":"24","author":"H Wang","year":"2024","unstructured":"Wang, H. et al. Development and validation of prediction models for papillary thyroid cancer structural recurrence using machine learning approaches. BMC Cancer 24(1), 427. https:\/\/doi.org\/10.1186\/s12885-024-12146-4 (2024).","journal-title":"BMC Cancer"},{"issue":"2","key":"50784_CR16","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1089\/thy.2016.0252","volume":"27","author":"SG Lee","year":"2017","unstructured":"Lee, S. G. et al. Practical performance of the 2015 American Thyroid Association guidelines for predicting tumor recurrence in patients with papillary thyroid cancer in South Korea. Thyroid 27(2), 174\u2013181. https:\/\/doi.org\/10.1089\/thy.2016.0252 (2017).","journal-title":"Thyroid"},{"issue":"1","key":"50784_CR17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.surg.2021.03.076","volume":"171","author":"AC Beck","year":"2022","unstructured":"Beck, A. C. et al. Expression of cancer stem cell markers in tall cell variant papillary thyroid cancer identifies a molecular profile predictive of recurrence in classic papillary thyroid cancer. Surgery 171(1), 245\u2013251. https:\/\/doi.org\/10.1016\/j.surg.2021.03.076 (2022).","journal-title":"Surgery"},{"issue":"7","key":"50784_CR18","doi-asserted-by":"publisher","first-page":"4772","DOI":"10.1245\/s10434-025-17256-2","volume":"32","author":"J Chang","year":"2025","unstructured":"Chang, J. et al. Risk of recurrence and cancer stem cell marker CD133 expression vary in males versus females with papillary thyroid cancer. Ann. Surg. Oncol. 32(7), 4772\u20134779. https:\/\/doi.org\/10.1245\/s10434-025-17256-2 (2025).","journal-title":"Ann. Surg. Oncol."},{"issue":"6","key":"50784_CR19","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1089\/thy.2018.0775","volume":"30","author":"A Zahedi","year":"2020","unstructured":"Zahedi, A. et al. Risk for thyroid cancer recurrence is higher in men than in women independent of disease stage at presentation. Thyroid 30(6), 871\u2013877. https:\/\/doi.org\/10.1089\/thy.2018.0775 (2020).","journal-title":"Thyroid"},{"issue":"11","key":"50784_CR20","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.2217\/fon.10.127","volume":"6","author":"R Rahbari","year":"2010","unstructured":"Rahbari, R., Zhang, L. & Kebebew, E. Thyroid cancer gender disparity. Future Oncol. 6(11), 1771\u20131779. https:\/\/doi.org\/10.2217\/fon.10.127 (2010).","journal-title":"Future Oncol."},{"key":"50784_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-025-03028-y","author":"M Khan","year":"2025","unstructured":"Khan, M. et al. Sex differences in cancer incidence: Prospective analyses in the UK Biobank. Br. J. Cancer. https:\/\/doi.org\/10.1038\/s41416-025-03028-y (2025).","journal-title":"Br. J. Cancer."},{"issue":"5","key":"50784_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1530\/ERC-24-0348","volume":"32","author":"F Coperchini","year":"2025","unstructured":"Coperchini, F. et al. Sexual dimorphism in thyroid cancer: Evidence from preclinical studies. Endocr. Relat. Cancer 32(5), 15. https:\/\/doi.org\/10.1530\/ERC-24-0348 (2025).","journal-title":"Endocr. Relat. Cancer"},{"issue":"3","key":"50784_CR23","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1089\/thy.2021.0361","volume":"32","author":"L Shobab","year":"2022","unstructured":"Shobab, L., Burman, K. D. & Wartofsky, L. Sex differences in differentiated thyroid cancer. Thyroid 32(3), 224\u2013235. https:\/\/doi.org\/10.1089\/thy.2021.0361 (2022).","journal-title":"Thyroid"},{"key":"50784_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.593479","volume":"11","author":"J Liu","year":"2021","unstructured":"Liu, J., Xu, T., Ma, L. & Chang, W. Signal pathway of estrogen and estrogen receptor in the development of thyroid cancer. Front. Oncol. 11, 593479. https:\/\/doi.org\/10.3389\/fonc.2021.593479 (2021).","journal-title":"Front. Oncol."},{"issue":"5","key":"50784_CR25","doi-asserted-by":"publisher","first-page":"T273","DOI":"10.1530\/ERC-14-0053","volume":"21","author":"M Derwahl","year":"2014","unstructured":"Derwahl, M. & Nicula, D. Estrogen and its role in thyroid cancer. Endocr. Relat. Cancer 21(5), T273\u2013T283. https:\/\/doi.org\/10.1530\/ERC-14-0053 (2014).","journal-title":"Endocr. Relat. Cancer"},{"key":"50784_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.916804","volume":"12","author":"Z Gong","year":"2022","unstructured":"Gong, Z. et al. The isoforms of estrogen receptor alpha and beta in thyroid cancer. Front. Oncol. 12, 916804. https:\/\/doi.org\/10.3389\/fonc.2022.916804 (2022).","journal-title":"Front. Oncol."},{"issue":"3","key":"50784_CR27","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1006\/geno.1997.4972","volume":"45","author":"C Carmeci","year":"1997","unstructured":"Carmeci, C., Thompson, D. A., Ring, H. Z., Francke, U. & Weigel, R. J. Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. Genomics 45(3), 607\u2013617. https:\/\/doi.org\/10.1006\/geno.1997.4972 (1997).","journal-title":"Genomics"},{"key":"50784_CR28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.abb.2017.09.002","volume":"633","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. Bisphenol A and estrogen induce proliferation of human thyroid tumor cells via an estrogen-receptor-dependent pathway. Arch. Biochem. Biophys. 633, 29\u201339. https:\/\/doi.org\/10.1016\/j.abb.2017.09.002 (2017).","journal-title":"Arch. Biochem. Biophys."},{"key":"50784_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/941568","volume":"2013","author":"W Dong","year":"2013","unstructured":"Dong, W. et al. Estrogen induces metastatic potential of papillary thyroid cancer cells through estrogen receptor alpha and beta. Int. J. Endocrinol. 2013, 941568. https:\/\/doi.org\/10.1155\/2013\/941568 (2013).","journal-title":"Int. J. Endocrinol."},{"issue":"3","key":"50784_CR30","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s40618-024-02473-5","volume":"48","author":"ZM Song","year":"2025","unstructured":"Song, Z. M. et al. Estrogen enhances the proliferation, migration, and invasion of papillary thyroid carcinoma via the ERalpha\/KRT19 signaling axis. J. Endocrinol. Invest 48(3), 653\u2013670. https:\/\/doi.org\/10.1007\/s40618-024-02473-5 (2025).","journal-title":"J. Endocrinol. Invest"},{"key":"50784_CR31","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.mce.2016.12.007","volume":"442","author":"P Zhu","year":"2017","unstructured":"Zhu, P. et al. GPER\/ERK&AKT\/NF-kappaB pathway is involved in cadmium-induced proliferation, invasion and migration of GPER-positive thyroid cancer cells. Mol. Cell. Endocrinol. 442, 68\u201380. https:\/\/doi.org\/10.1016\/j.mce.2016.12.007 (2017).","journal-title":"Mol. Cell. Endocrinol."},{"issue":"5","key":"50784_CR32","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3892\/ijo_00000588","volume":"36","author":"A Kumar","year":"2010","unstructured":"Kumar, A., Klinge, C. M. & Goldstein, R. E. Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta. Int. J. Oncol. 36(5), 1067\u20131080. https:\/\/doi.org\/10.3892\/ijo_00000588 (2010).","journal-title":"Int. J. Oncol."},{"issue":"4","key":"50784_CR33","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1124\/mol.106.026344","volume":"70","author":"A Vivacqua","year":"2006","unstructured":"Vivacqua, A. et al. 17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30. Mol. Pharmacol. 70(4), 1414\u20131423. https:\/\/doi.org\/10.1124\/mol.106.026344 (2006).","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"50784_CR34","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/j.1365-2184.2007.00471.x","volume":"40","author":"Q Zeng","year":"2007","unstructured":"Zeng, Q., Chen, G. G., Vlantis, A. C. & van Hasselt, C. A. Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor-ERK pathway. Cell Prolif. 40(6), 921\u2013935. https:\/\/doi.org\/10.1111\/j.1365-2184.2007.00471.x (2007).","journal-title":"Cell Prolif."},{"key":"50784_CR35","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.biopha.2016.11.043","volume":"85","author":"M Zane","year":"2017","unstructured":"Zane, M. et al. Estrogen and thyroid cancer is a stem affair: A preliminary study. Biomed. Pharmacother. 85, 399\u2013411. https:\/\/doi.org\/10.1016\/j.biopha.2016.11.043 (2017).","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"50784_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1077-9","volume":"9","author":"M Li","year":"2018","unstructured":"Li, M. et al. Estrogen receptor \u03b2 upregulated by lncRNA-H19 to promote cancer stem-like properties in papillary thyroid carcinoma. Cell Death Dis. 9(11), 1120. https:\/\/doi.org\/10.1038\/s41419-018-1077-9 (2018).","journal-title":"Cell Death Dis."},{"issue":"1","key":"50784_CR37","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1186\/s12885-023-11556-0","volume":"23","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. Estrogen-related genes for thyroid cancer prognosis, immune infiltration, staging, and drug sensitivity. BMC Cancer 23(1), 1048. https:\/\/doi.org\/10.1186\/s12885-023-11556-0 (2023).","journal-title":"BMC Cancer"},{"issue":"2","key":"50784_CR38","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/iub.1462","volume":"68","author":"S Hima","year":"2016","unstructured":"Hima, S. & Sreeja, S. Modulatory role of 17beta-estradiol in the tumor microenvironment of thyroid cancer. IUBMB Life 68(2), 85\u201396. https:\/\/doi.org\/10.1002\/iub.1462 (2016).","journal-title":"IUBMB Life"},{"key":"50784_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15092458","author":"N Denaro","year":"2023","unstructured":"Denaro, N. et al. The tumor microenvironment and the estrogen loop in thyroid cancer. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers15092458 (2023).","journal-title":"Cancers (Basel)"},{"issue":"7","key":"50784_CR40","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/rheumatology\/keq031","volume":"49","author":"T Horiuchi","year":"2010","unstructured":"Horiuchi, T., Mitoma, H., Harashima, S., Tsukamoto, H. & Shimoda, T. Transmembrane TNF-alpha: Structure, function and interaction with anti-TNF agents. Rheumatology (Oxford) 49(7), 1215\u20131228. https:\/\/doi.org\/10.1093\/rheumatology\/keq031 (2010).","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"50784_CR41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/ijms22052719","volume":"22","author":"DI Jang","year":"2021","unstructured":"Jang, D. I. et al. The role of tumor necrosis factor alpha (TNF-alpha) in autoimmune disease and current TNF-alpha inhibitors in therapeutics. Int. J. Mol. Sci. 22(5), 15. https:\/\/doi.org\/10.3390\/ijms22052719 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"50784_CR42","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","volume":"12","author":"GD Kalliolias","year":"2016","unstructured":"Kalliolias, G. D. & Ivashkiv, L. B. TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nat. Rev. Rheumatol. 12(1), 49\u201362. https:\/\/doi.org\/10.1038\/nrrheum.2015.169 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"issue":"29","key":"50784_CR43","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.2174\/092986710793176339","volume":"17","author":"L Bertazza","year":"2010","unstructured":"Bertazza, L. & Mocellin, S. The dual role of tumor necrosis factor (TNF) in cancer biology. Curr. Med. Chem. 17(29), 3337\u20133352. https:\/\/doi.org\/10.2174\/092986710793176339 (2010).","journal-title":"Curr. Med. Chem."},{"issue":"11","key":"50784_CR44","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1111\/j.1745-7254.2008.00889.x","volume":"29","author":"X Wang","year":"2008","unstructured":"Wang, X. & Lin, Y. Tumor necrosis factor and cancer, buddies or foes?. Acta Pharmacol. Sin. 29(11), 1275\u20131288. https:\/\/doi.org\/10.1111\/j.1745-7254.2008.00889.x (2008).","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"50784_CR45","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1677\/joe.0.1780205","volume":"178","author":"CS Mitsiades","year":"2003","unstructured":"Mitsiades, C. S., Poulaki, V. & Mitsiades, N. The role of apoptosis-inducing receptors of the tumor necrosis factor family in thyroid cancer. J. Endocrinol. 178(2), 205\u2013216. https:\/\/doi.org\/10.1677\/joe.0.1780205 (2003).","journal-title":"J. Endocrinol."},{"issue":"1","key":"50784_CR46","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s12672-025-01815-w","volume":"16","author":"Y Zhao","year":"2025","unstructured":"Zhao, Y., Zhao, S., Fan, Z., Zhao, Y. & Wang, G. Relationship between programmed cell death and targeted therapy for thyroid cancer in patients with a poor prognosis: An update. Discov. Oncol. 16(1), 112. https:\/\/doi.org\/10.1007\/s12672-025-01815-w (2025).","journal-title":"Discov. Oncol."},{"issue":"3","key":"50784_CR47","doi-asserted-by":"publisher","first-page":"376","DOI":"10.4183\/aeb.2023.376","volume":"19","author":"S Uslu","year":"2023","unstructured":"Uslu, S. Papillary thyroid carcinoma following adalimumab treatment in ankylosing spondylitis: A causal or coincidental association?. Acta Endocrinol. (Buchar) 19(3), 376\u2013379. https:\/\/doi.org\/10.4183\/aeb.2023.376 (2023).","journal-title":"Acta Endocrinol. (Buchar)"},{"key":"50784_CR48","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8143695","author":"TP Kobawala","year":"2016","unstructured":"Kobawala, T. P. et al. Significance of TNF-alpha and the adhesion molecules: L-selectin and VCAM-1 in papillary thyroid carcinoma. J. Thyroid Res. https:\/\/doi.org\/10.1155\/2016\/8143695 (2016).","journal-title":"J. Thyroid Res."},{"key":"50784_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15060791","author":"KJ Bae","year":"2025","unstructured":"Bae, K. J., Bae, J. H., Oh, A. C. & Cho, C. H. Comparison of 46 cytokines in peripheral blood between patients with papillary thyroid cancer and healthy individuals with AI-driven analysis to distinguish between the two groups. Diagnostics https:\/\/doi.org\/10.3390\/diagnostics15060791 (2025).","journal-title":"Diagnostics"},{"issue":"1","key":"50784_CR50","doi-asserted-by":"publisher","first-page":"15316","DOI":"10.1038\/s41598-025-00255-4","volume":"15","author":"M Cwiklinska-Dworakowska","year":"2025","unstructured":"Cwiklinska-Dworakowska, M. et al. Preliminary results suggest the potential of evaluating combined bFGF and TNF-beta concentrations for differentiating papillary thyroid cancer from benign nodular goiter. Sci Rep 15(1), 15316. https:\/\/doi.org\/10.1038\/s41598-025-00255-4 (2025).","journal-title":"Sci Rep"},{"issue":"3","key":"50784_CR51","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3892\/etm_00000071","volume":"1","author":"K Jensen","year":"2010","unstructured":"Jensen, K. et al. Dynamic changes in E-cadherin gene promoter methylation during metastatic progression in papillary thyroid cancer. Exp. Ther. Med. 1(3), 457\u2013462. https:\/\/doi.org\/10.3892\/etm_00000071 (2010).","journal-title":"Exp. Ther. Med."},{"issue":"4","key":"50784_CR52","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.1007\/s13277-015-4418-7","volume":"37","author":"F Coperchini","year":"2016","unstructured":"Coperchini, F. et al. TNF-alpha increases the membrane expression of the chemokine receptor CCR6 in thyroid tumor cells, but not in normal thyrocytes: Potential role in the metastatic spread of thyroid cancer. Tumour Biol. 37(4), 5569\u20135575. https:\/\/doi.org\/10.1007\/s13277-015-4418-7 (2016).","journal-title":"Tumour Biol."},{"issue":"9","key":"50784_CR53","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.7150\/jca.53349","volume":"12","author":"N Lv","year":"2021","unstructured":"Lv, N., Liu, F., Cheng, L., Liu, F. & Kuang, J. The expression of transcription factors is different in papillary thyroid cancer cells during tnf\u2014alpha induced EMT. J Cancer 12(9), 2777\u20132786. https:\/\/doi.org\/10.7150\/jca.53349 (2021).","journal-title":"J Cancer"},{"issue":"6","key":"50784_CR54","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1177\/09622802211002867","volume":"30","author":"PC Austin","year":"2021","unstructured":"Austin, P. C., Harrell, F. E. Jr. & Steyerberg, E. W. Predictive performance of machine and statistical learning methods: Impact of data-generating processes on external validity in the \u201clarge N, small p\u201d setting. Stat. Methods Med. Res. 30(6), 1465\u20131483. https:\/\/doi.org\/10.1177\/09622802211002867 (2021).","journal-title":"Stat. Methods Med. Res."},{"issue":"5","key":"50784_CR55","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1089\/thy.2019.0688","volume":"30","author":"P Trimboli","year":"2020","unstructured":"Trimboli, P. et al. Patient age is an independent risk factor of relapse of differentiated thyroid carcinoma and improves the performance of the American Thyroid Association stratification system. Thyroid 30(5), 713\u2013719 (2020).","journal-title":"Thyroid"},{"issue":"11","key":"50784_CR56","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1089\/thy.2024.0271","volume":"34","author":"DJ van de Berg","year":"2024","unstructured":"van de Berg, D. J. et al. The definition of recurrence of differentiated thyroid cancer: A systematic review of the literature. Thyroid 34(11), 1324\u20131334 (2024).","journal-title":"Thyroid"},{"issue":"43","key":"50784_CR57","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A. 102(43), 15545\u201315550. https:\/\/doi.org\/10.1073\/pnas.0506580102 (2005).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"50784_CR58","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha, V. K. et al. PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34(3), 267\u2013273. https:\/\/doi.org\/10.1038\/ng1180 (2003).","journal-title":"Nat. Genet."},{"issue":"2","key":"50784_CR59","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","volume":"173","author":"KA Hoadley","year":"2018","unstructured":"Hoadley, K. A. et al. Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer. Cell 173(2), 291\u2013304. https:\/\/doi.org\/10.1016\/j.cell.2018.03.022 (2018).","journal-title":"Cell"},{"key":"50784_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen, E. Y. et al. Enrichr: Interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14, 128 (2013).","journal-title":"BMC Bioinformatics"},{"key":"50784_CR61","first-page":"2825","volume":"12","author":"M Pedregosa","year":"2011","unstructured":"Pedregosa, M. et al. Scikit-learn: Machine learning in python. JMLR 12, 2825\u20132830 (2011).","journal-title":"JMLR"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50784-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50784-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50784-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:14:51Z","timestamp":1783422891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50784-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["50784"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-50784-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"5 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20809"}}